methamphetamine use disorder
Information
- Disease name
- methamphetamine use disorder
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04907357 | Active, not recruiting | N/A | rTMS for Stimulant Use Disorders | February 4, 2022 | July 2024 |
| NCT06279273 | Active, not recruiting | N/A | A Study for the Risky Decision-making Deficits Among Methamphetamine Dependence Individuals and Treatment | January 1, 2023 | December 31, 2025 |
| NCT04791969 | Active, not recruiting | Phase 2 | Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM | December 14, 2021 | July 1, 2024 |
| NCT04178993 | Completed | Phase 1 | Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine] | September 1, 2019 | May 5, 2021 |
| NCT04713124 | Completed | N/A | A Telephone-delievered Intervention to Reduce Methamphetamine Use | February 4, 2021 | January 25, 2024 |
| NCT00572234 | Completed | N/A | Bupropion in the Treatment of Methamphetamine Dependence | August 31, 2007 | May 20, 2011 |
| NCT01982643 | Completed | Phase 1/Phase 2 | Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder | November 2013 | February 2015 |
| NCT03078075 | Completed | Phase 3 | Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder | May 5, 2017 | July 25, 2019 |
| NCT06320366 | Not yet recruiting | N/A | Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder | July 1, 2024 | May 31, 2028 |
| NCT05322954 | Recruiting | Phase 1 | Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder | March 3, 2023 | May 2025 |
| NCT05558358 | Recruiting | Phase 1/Phase 2 | Deep Brain Stimulation (DBS) for Methamphetamine Use Disorder | January 15, 2024 | February 1, 2025 |
| NCT04614584 | Recruiting | Phase 1 | Mirtazapine and Methamphetamine Drug-drug Interaction Study | July 12, 2021 | December 31, 2025 |
| NCT06033365 | Recruiting | N/A | Beginning Early and Assertive Treatment for Methamphetamine Use Disorder | April 11, 2023 | September 2025 |
| NCT05760807 | Recruiting | N/A | Intranasal Oxytocin for Methamphetamine Withdrawal in Women | March 29, 2023 | June 2024 |
| NCT03106571 | Terminated | Phase 1 | Study of Pomaglumetad and Methamphetamine | August 1, 2017 | July 31, 2020 |
| NCT05711862 | Terminated | Phase 2 | The Effects of Suvorexant on Sleep, Stress, and Cue-reactivity in Methamphetamine Use Disorder | March 9, 2023 | March 28, 2024 |